Nine medications, multiple therapists, and a drug-resistant depression that ran through most of his adult life. Then Jim Ellwood, an anesthesiologist who spent a career giving ketamine as an anesthetic, tried it on himself. He explains what the Matthew Perry headlines distorted, how the drug works in the brain, and the questions to ask before letting any clinic dose you.

⏱️ Chapters:
0:00 Introduction
0:23 Nine medications, and none of them worked
4:03 The horse drug, the K hole, and the headlines
5:21 Michael Jackson did not die because propofol is unsafe
7:25 What ketamine actually feels like
9:31 How often it works, and how much is hype
10:14 The addiction risk nobody should skip past
11:05 What the brain research shows, and why the effect fades
12:42 The medical director loophole behind some clinics
14:57 What to ask before you dose yourself at home
16:17 The drug combinations that turn this dangerous
17:41 When to raise ketamine with your own patients
19:03 The drug company conference he still thinks about
19:57 The insurance wall, and what a session costs
21:44 Take home messages

About this episode:
Jim Ellwood spent a career as an anesthesiologist giving ketamine in the operating room, and he also lives with a treatment-resistant depression that nine medications and multiple therapists could not resolve. Two years ago, after another failed trial, he asked his psychiatrist about ketamine and ended up in a monitored program run by emergency physicians, where a two-week induction produced a shift in mood he could feel. He wrote about it publicly because he wanted other clinicians to see a doctor say out loud that he needed help and found it. In this conversation he takes on the reaction that followed the Matthew Perry and Elon Musk coverage, and argues the same thing happened to propofol after Michael Jackson and to fentanyl after Prince and Tom Petty, where a useful drug got judged entirely by how it was misused. He walks through the research, from glutamate and opioid pathway activity to recent Weill Cornell work on interneurons, the prefrontal cortex, and brain-derived neurotrophic factor, and he is direct that the antidepressant effect fades, which is why he still goes weekly. He is equally direct about the risks, including addiction potential, interactions with benzodiazepines and seizure medications, and the dosing uncertainty around oral and at-home routes. For patients looking at the clinics now advertising everywhere, he explains the medical director arrangement that lets a physician with no relevant expertise sign off on a service, and gives the specific questions to ask about who is prescribing, who is present if something goes wrong, and who helps you make sense of the experience afterward. He closes on cost, insurance, stigma, and one message for anyone convinced that nothing is going to work.

🤝 This episode is brought to you by ModMed:
Welcome to your new AI-Powered Practice from ModMed. We're transforming specialty care by embedding AI Assistants across your entire workflow. Our all-in-one platform of EHR, patient engagement, practice management, and RCM helps reduce repetitive work while keeping you firmly in control. Trained on de-identified data from nearly a billion patient encounters, this isn't just smarter software. It's a new way of working for specialty medicine, more efficient and more connected to the patient experience. Start building your AI-Powered Practice at modmed.com.

➡️ VISIT SPONSOR: https://www.modmed.com/

🤝 Partner with me on the KevinMD platform:
With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Let's work together to tell your story.

➡️ PARTNER WITH KEVINMD: https://kevinmd.com/influencer
➡️ SUBSCRIBE TO THE PODCAST: https://www.kevinmd.com/podcast
➡️ RECOMMENDED BY KEVINMD: https://www.kevinmd.com/recommended

#Ketamine #TreatmentResistantDepression #PhysicianMentalHealth